{"id":14834,"date":"2022-05-27T11:28:00","date_gmt":"2022-05-27T11:28:00","guid":{"rendered":"https:\/\/www.embl.org\/about\/info\/alumni\/?page_id=14834"},"modified":"2022-08-17T10:02:07","modified_gmt":"2022-08-17T10:02:07","slug":"michael-sela","status":"publish","type":"page","link":"https:\/\/www.embl.org\/about\/info\/alumni\/community\/obituaries\/michael-sela\/","title":{"rendered":"Michael Sela"},"content":{"rendered":"\n<div class=\"vf-grid | vf-grid__col-3\"><div class=\"vf-grid__col--span-2\"><!--[vf\/content]-->\n<div class=\"vf-content\">\n\n<h2 class=\"wp-block-heading\">Michael Sela, former EMBL Scientific Advisory Committee (SAC) member, passed away on 27 May 2022 at the age of 98.<\/h2>\n\n\n\n<p><meta charset=\"utf-8\">It is with sadness that we share the news of the passing of distinguished immunologist Michael Sela. An EMBL SAC member from 1976-1981, Michael&#8217;s academic career spanned more than 70 years at the Weizmann Institute of Science in Rehovot, Israel, where he was President for a decade from 1975-1985. He was especially known for his research on synthetic antigens, as well as being the co-developer of the multiple sclerosis drug copaxone. Serving in various leadership roles throughout his career, Michael is remembered as a leader of science on a global scale who maintained a strong commitment to EMBO and EMBL. May he rest in peace.<\/p>\n\n\n\n<p>If you would like to add a message of condolence, please contact the&nbsp;<a href=\"mailto:alumni@embl.org\">Alumni Relations team<\/a>.<\/p>\n\n<\/div>\n<\/div>\n\n\n<div class=\"\"><!--[vf\/content]-->\n<div class=\"vf-content\">\n\n<figure class=\"vf-figure wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"156\" height=\"180\" class=\"vf-figure__image\" src=\"https:\/\/www.embl.org\/about\/info\/alumni\/wp-content\/uploads\/2022\/08\/Prof.-Michael-Sela-10997F22-photo-by-Itai-Belson-Weizmann-Institu-156x180-1.jpg\" alt=\"\" class=\"wp-image-14891\"\/><figcaption class=\"vf-figure__caption\">Michael Sela<em> (Image: Itai Belson &#8211; The Weizmann Institute of Science)<\/em><\/figcaption><\/figure>\n\n\n\n<p><\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":0,"parent":498,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-title-left-aligned.php","meta":{"_acf_changed":false,"footnotes":""},"embl_taxonomy":[],"class_list":["post-14834","page","type-page","status-publish","hentry"],"acf":[],"embl_taxonomy_terms":[],"_links":{"self":[{"href":"https:\/\/www.embl.org\/about\/info\/alumni\/wp-json\/wp\/v2\/pages\/14834","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/about\/info\/alumni\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.embl.org\/about\/info\/alumni\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/about\/info\/alumni\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/about\/info\/alumni\/wp-json\/wp\/v2\/comments?post=14834"}],"version-history":[{"count":5,"href":"https:\/\/www.embl.org\/about\/info\/alumni\/wp-json\/wp\/v2\/pages\/14834\/revisions"}],"predecessor-version":[{"id":14903,"href":"https:\/\/www.embl.org\/about\/info\/alumni\/wp-json\/wp\/v2\/pages\/14834\/revisions\/14903"}],"up":[{"embeddable":true,"href":"https:\/\/www.embl.org\/about\/info\/alumni\/wp-json\/wp\/v2\/pages\/498"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/about\/info\/alumni\/wp-json\/wp\/v2\/media?parent=14834"}],"wp:term":[{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/about\/info\/alumni\/wp-json\/wp\/v2\/embl_taxonomy?post=14834"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}